Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada

Study Identifier
P19-933
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Endometriosis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female
    Age
    18 - 50 Years

    Protocol Summary

    The objective of this study is to evaluate real-world effectiveness of elagolix in Canadian women with endometriosis.

    Study Locations

    Location
    Status
    Location
    South Health Campus Rheumatology Clinic /ID# 213065
    Calgary, Alberta, Canada, T3M 1M4
    Status
    Not applicable
    Location
    Aubrey D. Uretsky Professional Corporation /ID# 214753
    Edmonton, Alberta, Canada, T5T 1L6
    Status
    Not applicable
    Location
    BC Women's Hospital /ID# 214561
    Vancouver, British Columbia, Canada, V6H 2N9
    Status
    Not applicable
    Location
    Strand Clinic /ID# 213567
    St. John's, Newfoundland and Labrador, Canada, A1A 4Y3
    Status
    Not applicable
    Location
    IWK Health Center /ID# 213066
    Halifax, Nova Scotia, Canada, B3K 6R8
    Status
    Not applicable
    Location
    Medicor Research Inc /ID# 213467
    Greater Sudbury, Ontario, Canada, P3A 1W8
    Status
    Not applicable
    Showing {first} - {last} of {total} Results